Jump to content

Covid-19: Razvoj vakcine, imunitet i primena medikamenata

bey
bey
in Covid-19 Coronavirus

Featured Replies

Just now, precog said:

gde si to nasao, prilicno, hm, smela tvrdnja?

Kako gde, pa pun vajber tog forvarda, obično ide u paketu sa proročanstvima svetog oca Gavrila iz manastira Bošnjani.

    • +1 1

    I meni izgleda kao lažna vest, posebno uzimajući u obzir datum vesti - kraj maja. Dosad bi se više znalo da je put bio ispravan.

    Doterani Google translate prevod suštinskog dela:

    Двадесет и пет пацијената са тешким обликом ковид-19 током три недеље лечено је у Клиници "Јеан Митрев" методом хемофилтрације, објаснио је др. Митрев у јучерашњем видео обраћању.



    - Сви примљени пацијенти имали су тешке симптоме ковид инфекције. Наш концепт лечења прво подразумева праћење инфективних параметара, одређујемо инфмламаторни индекс тог пацијента и ако се стање плућа погорша, одмах идемо на хемофилтрацију, пречишћавање крви која траје 24 или 48 сати, а код неких пацијената у тешком стању и дуже. До сада је лечено 25 пацијената са индикацијом да се ставе на респиратор, што смо избегли применом овог метода. Више од половине пацијената већ је код куће, а остали се опорављају - каже Митрев, наглашавајући да је тај резултат последица дугогодишњег искуства Клинике са пацијентима са сепсом.

    ne kaze kolika je cijena te hemofiltracije. prava sitnica? samo za milijunase?

     

    Hemofiltracija snižava nivo citokina u krvi?

    Edited by slow

    MOSCOW (Reuters) - Russia has approved a new antiviral drug, Coronavir, to treat COVID-19 patients, its developer R-Pharm said on Wednesday, as Russia’s tally of infections hit 700,000.



    It said a clinical trial involving mild or medium-level cases had shown the drug to be highly effective in inhibiting replication of the new coronavirus.

    “Coronavir is one of the first drugs in Russia and in the world that does not tackle the complications caused by SARS-CoV-2, but battles the virus itself,” the company’s statement said.

    It said a clinical study showed improvement in 55% of outpatient cases on the seventh day of treatment with Coronavir, against 20% of those with standard etiotropic therapy - meaning treatment of cause rather than symptoms. R-Pharm said there was also a significant difference at 14 days.

    By the fifth day of treatment, the novel coronavirus had been eliminated in 77.5% of patients who took the drug, R-Pharm said.

    “Global clinical practice and the clinical study we conducted have confirmed that Coronavir puts a much more rapid stop to the infection as a result of its effective obstruction of the virus’s replication,” Mikhail Samsonov, R-Pharm’s medical director, was cited as saying.

    Testing began in late May and over 110 outpatients have now received the treatment, the head of clinical trials at Russia’s Central Research Institute of Epidemiology, Tatyana Ryzhentsova, was cited as saying.

    The drug is the third registered in Russia to treat the new coronavirus. The first, Avifavir, has been given to patients since June 11.
    ...


    https://www.reuters.com/article/us-health-coronavirus-russia-drug/russian-firm-gets-approval-for-drug-said-to-block-coronavirus-replication-idUSKBN2492RF
    • +1 1
    • Wub 1

    Nije u pitanju nikakav proboj, jer je aktivna supstanca ista kao i u prethodna dva ruska leka.

    Quote

    Coronavir is based on the same active ingredient as the other drugs approved by the Ministry of Health to fight the infection - Favipiravir. It is a part of preparations under the trade name "Avifavir" (it was the first drug against COVID-19, approved for use by Russia) and "Areplivir".

    The Ministry of Health decided to conduct clinical trials of Favipiravir in April. The agency also noted that during clinical trials on humans, the effectiveness of "Avifavir" was 90%. In June, it was delivered to 35 regions of Russia, as well as Belarus, and in the near future it will be delivered to Kazakhstan. The head of the Russian Direct Investment Fund, Kirill Dmitriev, promised that the drug would be provided free of charge as part of the mandatory health insurance.

    https://www.rbc.ru/rbcfreenews/5f05d1f69a7947c3dcc66cf7. (translation by Deepl)

    Edited by vememah

    Da li se taj lek koristi van Rusije?

    Najviše se uzdam u tu vakcinu. Ali ovde će biti neka kineska.

    Ta vakcina ne sprečava širenje virusa već samo čini da se zaraženi ne razbole. To može značiti da će u zemljama u kojima se ona bude koristila nastradati oni koji ne budu smeli/mogli/hteli da je prime.

     

    Go to topic listing